The COVID-19 and Cardiovascular Nexus

Anthony DeMaria MDJudy and Jack White Chair in Cardiology

University of California, San Diego

COVID-19 and Cardiovascular Disease

• Patients with CV disease are very susceptible

• CV Disease pts have more severe illness and outcome

• Infection can activate quiescent CV disease

• Evidence for myocardial injury (Myocarditis)

• Effect of CV drugs on course of disease

• Therapeutics and CV disease

Cardiovascular Disease Predisposes to COVID-19

Cardiovascular Disease Confers a Worse Outcome with COVID-19

Characteristics of Patients with COVID-19

Myocardial Injury with COVID-19

Therapeutics and COVID-19

COVID-19 and Cardiovascular Disease

• Patients with CV disease are very susceptible

• CV Disease pts have more severe illness and outcome

• Infection can activate quiescent CV disease

• Evidence for myocardial injury (Myocarditis)

• Effect of CV drugs on course of disease

• Therapeutics and CV disease